{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:57:02Z","timestamp":1776931022550,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6855","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1038\/35097089","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:32:58Z","timestamp":1027672378000},"page":"527-531","source":"Crossref","is-referenced-by-count":612,"title":["An endogenous cannabinoid (2-AG) is neuroprotective after brain injury"],"prefix":"10.1038","volume":"413","author":[{"given":"David","family":"Panikashvili","sequence":"first","affiliation":[]},{"given":"Constantina","family":"Simeonidou","sequence":"additional","affiliation":[]},{"given":"Shimon","family":"Ben-Shabat","sequence":"additional","affiliation":[]},{"given":"Lum\u00edr","family":"Hanu\u0161","sequence":"additional","affiliation":[]},{"given":"Aviva","family":"Breuer","sequence":"additional","affiliation":[]},{"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[]},{"given":"Esther","family":"Shohami","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF35097089_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/neu.1995.12.555","volume":"12","author":"JT Povlishock","year":"1995","unstructured":"Povlishock, J. T. & Christman, C. W. The pathobiology of traumatically induced axonal injury in animals and humans: A review of current thoughts. J. Neurotrauma 12, 555\u2013564 (1995).","journal-title":"J. Neurotrauma"},{"key":"BF35097089_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00130478-200007000-00003","volume":"1","author":"PM Kochanek","year":"2000","unstructured":"Kochanek, P. M. et al. Biochemical, cellular, and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: Lessons learned from the bedside. Pediatr. Crit. Care Med. 1, 4\u201319 (2000).","journal-title":"Pediatr. Crit. Care Med."},{"key":"BF35097089_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam, R. et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83\u201390 (1995).","journal-title":"Biochem. Pharmacol."},{"key":"BF35097089_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura, T. et al. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89\u201397 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF35097089_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(98)00649-9","volume":"359","author":"R Mechoulam","year":"1998","unstructured":"Mechoulam, R., Fride, E. & Di Marzo, V. Endocannabinoids. Eur. J. Pharmacol. 359, 1\u201318 (1998).","journal-title":"Eur. J. Pharmacol."},{"key":"BF35097089_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0165-6147(00)01482-6","volume":"21","author":"D Piomelli","year":"2000","unstructured":"Piomelli, D., Giuffrida, A., Calignano, A. & Rodriguez de Fonseca, F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol. Sci. 21, 218\u2013223 (2000).","journal-title":"Trends Pharmacol. Sci."},{"key":"BF35097089_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1023\/A:1022418217479","volume":"23","author":"J Axelrod","year":"1998","unstructured":"Axelrod, J. & Felder, C. C. Cannabinoid receptors and their endogenous agonist, anandamide. Neurochem. Res. 23, 575\u2013581 (1998).","journal-title":"Neurochem. Res."},{"key":"BF35097089_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1089\/neu.1998.15.731","volume":"15","author":"TK McIntosh","year":"1998","unstructured":"McIntosh, T. K., Juhler, M. & Wieloch, T. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury J. Neurotrauma 15, 731\u2013769 (1998).","journal-title":"J. Neurotrauma"},{"key":"BF35097089_CR9","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1016\/S0014-2999(00)00653-1","volume":"406","author":"R Gallily","year":"2000","unstructured":"Gallily, R., Breuer, A. & Mechoulam, R. 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor \u03b1 production in murine macrophages, and in mice. Eur. J. Pharmacol. 406, R5\u2013R7 (2000).","journal-title":"Eur. J. Pharmacol."},{"key":"BF35097089_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00004647-200101000-00002","volume":"21","author":"PH Chan","year":"2001","unstructured":"Chan, P. H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21, 2\u201314 (2001).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BF35097089_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1359-6101(99)00008-8","volume":"10","author":"E Shohami","year":"1999","unstructured":"Shohami, E., Ginis, I. & Hallenbeck, J. M. Dual role of tumor necrosis factor \u03b1 in brain injury. Cytokines Growth Factor Rev. 10, 119\u2013130 (1999).","journal-title":"Cytokines Growth Factor Rev."},{"key":"BF35097089_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/neu.1996.13.557","volume":"13","author":"Y Chen","year":"1996","unstructured":"Chen, Y., Constantini, S., Trembovler, V., Weinstock, M. & Shohami, E. An experimental model of closed head injury in mice: Pathophysiology, histopathology and cognitive deficits. J. Neurotrauma 13, 557\u2013568 (1996).","journal-title":"J. Neurotrauma"},{"key":"BF35097089_CR13","first-page":"57","volume":"296","author":"L Beni-Adani","year":"2001","unstructured":"Beni-Adani, L. et al. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296, 57\u201363 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF35097089_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0165-0270(00)00277-6","volume":"102","author":"KS Mathews","year":"2000","unstructured":"Mathews, K. S. et al. Rapid quantification of ischaemic injury and cerebroprotection in brain slices using densitometric assessment of 2,3,5-triphenyltetrazolium chloride staining. J.\u00a0Neurosci. Meth. 102, 43\u201351 (2000).","journal-title":"J.\u00a0Neurosci. Meth."},{"key":"BF35097089_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","volume":"353","author":"S Ben-Shabat","year":"1998","unstructured":"Ben-Shabat, S. et al. An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl glycerol cannabinoid activity. Eur. J. Pharmacol. 353, 23\u201331 (1998).","journal-title":"Eur. J. Pharmacol."},{"key":"BF35097089_CR16","first-page":"1209","volume":"284","author":"IE Adams","year":"1998","unstructured":"Adams, I. E., Compton, D. R. & Martin, B. R. Assessment of anandamide interaction with the cannabinoid brain receptor: SR141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther. 284, 1209\u20131217 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF35097089_CR17","first-page":"136","volume":"293","author":"SR Smith","year":"2000","unstructured":"Smith, S. R., Terminelli, C. & Denhardt, G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J. Pharmacol. Exp. Ther. 293, 136\u2013150 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF35097089_CR18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1471-4159.1989.tb08550.x","volume":"53","author":"E Shohami","year":"1989","unstructured":"Shohami, E., Shapira, Y., Yadid, G., Reisfeld, N. & Yedgar, S. Brain phospholipase A2 is activated after experimental closed head injury in rats. J. Neurochem. 53, 1541\u20131546 (1989).","journal-title":"J. Neurochem."},{"key":"BF35097089_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(95)00367-Y","volume":"685","author":"V Nadler","year":"1995","unstructured":"Nadler, V., Biegon, A., Beit-Yannai, E., Adamchik, J. & Shohami, E. 45Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211. Brain Res. 685, 1\u201311 (1995).","journal-title":"Brain Res."},{"key":"BF35097089_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0009-3084(00)00185-7","volume":"108","author":"PH Reggio","year":"2000","unstructured":"Reggio, P. H. & Traore, H. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase. Chem. Phys. Lipids 108, 15\u201335 (2000).","journal-title":"Chem. Phys. Lipids"},{"key":"BF35097089_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0014-5793(97)01603-7","volume":"422","author":"SK Goparaju","year":"1998","unstructured":"Goparaju, S. K., Ueda, N., Yamaguchi, H. & Yamamoto, S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett. 422, 69\u201373 (1998).","journal-title":"FEBS Lett."},{"key":"BF35097089_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0304-3940(99)00922-2","volume":"278","author":"AD Sinor","year":"2000","unstructured":"Sinor, A. D., Irvin, S. M. & Greenberg, D. A. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci. Lett. 278, 157\u2013160 (2000).","journal-title":"Neurosci. Lett."},{"key":"BF35097089_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/mol.54.3.459","volume":"54","author":"M Shen","year":"1998","unstructured":"Shen, M. & Thayer, S. A. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol. Pharmacol. 54, 459\u2013462 (1998).","journal-title":"Mol. Pharmacol."},{"key":"BF35097089_CR24","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1523\/JNEUROSCI.19-08-02987.1999","volume":"19","author":"T Nagayama","year":"1999","unstructured":"Nagayama, T. et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 19, 2987\u20132995 (1999).","journal-title":"J. Neurosci."},{"key":"BF35097089_CR25","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1523\/JNEUROSCI.21-17-06475.2001","volume":"21","author":"M van der Stelt","year":"2001","unstructured":"van der Stelt, M. et al. Neuroprotectin by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. J. Neurosci. 21, 6475\u20136479 (2001).","journal-title":"J. Neurosci."},{"key":"BF35097089_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0009-3084(00)00192-4","volume":"108","author":"HS Hansen","year":"2000","unstructured":"Hansen, H. S., Moesgaard, B., Hansen, H. H. & Petersen, G. N-acylethanolamines and percursor phospholipids\u2014relation to cell injury. Chem. Phys. Lipids 108, 135\u2013150 (2000).","journal-title":"Chem. Phys. Lipids"},{"key":"BF35097089_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<211::AID-DDR3>3.0.CO;2-G","volume":"50","author":"E Shohami","year":"2000","unstructured":"Shohami, E. & Mechoulam, R. Dexanabinol (HU-211): A nonpsychotropic cannabinoid with neuroprotective properties. Drug Develop. Res. 50, 211\u2013215 (2000).","journal-title":"Drug Develop. Res."},{"key":"BF35097089_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1006\/bbrc.2000.2686","volume":"271","author":"T Sugiura","year":"2000","unstructured":"Sugiura, T., Yoshinaga, N., Kondo, S., Waku, K. & Ishima, Y. Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. Biochem. Biophys. Res. Comm. 271, 654\u2013658 (2000).","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"BF35097089_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1525-1373.2000.22501.x","volume":"225","author":"TW Klein","year":"2000","unstructured":"Klein, T. W., Lane, B., Newton, C. A. & Friedman, H. The cannabinoid system and cytokine network. Proc. Soc. Exp. Biol. Med. 225, 1\u20138 (2000).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF35097089_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0028-3908(94)00133-D","volume":"34","author":"H Ovadia","year":"1995","unstructured":"Ovadia, H., Wohlman, A., Mechoulam, R. & Weidenfeld, J. Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 34, 175\u2013180 (1995).","journal-title":"Neuropharmacology"},{"key":"BF35097089_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/01.RES.87.4.323","volume":"87","author":"Y Chen","year":"2000","unstructured":"Chen, Y. et al. Human brain capillary endothelium. 2-Arachidonoylglycerol (endocannabinoid) interacts with endothelin-1. Circ. Res. 87, 323\u2013327 (2000).","journal-title":"Circ. Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/35097089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35097089","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/35097089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/35097089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T02:11:25Z","timestamp":1684289485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/35097089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":31,"journal-issue":{"issue":"6855","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["BF35097089"],"URL":"https:\/\/doi.org\/10.1038\/35097089","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}